The Rainwater Charitable Foundation’s Medical Research Program funds innovative research on tauopathies, supporting studies that advance understanding and treatment of tau-related neurodegenerative diseases.
PTC-EM-AI Funding Program supports researchers advancing AI-discovered therapies through lead optimization and IND-enabling work to develop disease-modifying treatments for Alzheimer’s and related dementias.
The PTC-CTP grant from the Alzheimer's Association funds biomarker-driven clinical trials testing combination therapies for Alzheimer’s disease and related dementias.
Accelerating Drug Discovery for FTD supports investigators developing small molecule and biologic drugs through lead optimization and animal-model testing to advance disease-modifying treatments for FTD.
Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.